Bone resorption marker RANKL in the diagnosis and treatment of patients with maxillary sinus cysts

Background. RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand) is a protein belonging to the tumor necrosis factor superfamily serving as a specific marker for osteoclast activation and osteolysis. Aim. To determine RANKL levels in the homogenates of Maxillary Sinus Cysts (MSC) at the time of their removal, investigate the correlation of these indicators with the presence of pathology in the upper row of projection teeth in the respective patients, and refine the timing for potential dental implantation or sinus lifting after sinusotomy based on these findings. Materials & Methods. The study included 25 patients aged 20–65 years who underwent surgical treatment for MSCs located on the inferior wall of the sinus. The research methods comprised general clinical, otorhinolaryngological, radiological, and pathohistological techniques and Enzyme-Linked ImmunoSorbent Assay (ELISA) for RANKL in the tissues of the removed cysts. Pathohistological examination revealed retention cysts in 11 patients and pseudocysts in 14 patients. The presence of dental pathology and active odontogenic processes at the time of cyst removal was established based on prospective clinical and radiological evaluations. The dynamics of mucoperiosteal defect regeneration in the MSC, considering RANKL levels, were assessed 3–6 months post-surgery. Results. In the postoperative period, 8 (32%) out of 25 patients exhibited odontogenic alteration processes in the tissues of the maxilla adjacent to the cysts. The RANKL concentration in these patients was [80.65±34.22] pg/µg of protein, while in the other 17 patients without signs of bone damage, it was [33.10±4.35] pg/µg of protein (p<0.05). The threshold RANKL concentration distinguishing these groups in this study was 51.50 pg/µg of protein. Conclusions. In patients with peri-apical bone changes in the maxilla in the projection area of the cysts (alveolar recess), the RANKL level in their homogenates is higher compared to patients without such pathology. Measuring RANKL levels in the homogenates of cysts removed during endonasal maxillary sinusotomy can serve as an additional indicator for planning postoperative dental treatment in these patients. Keywords: ENT-pathology, endoscopic rhinosurgery, histology, postoperative period, paranasal sinus x-ray, treatment.

Authors

Institutions

Publication Details

Journal
Inter Collegas
Published
2024-09-30
DOI
https://doi.org/10.35339/ic.11.3.shn
Citations
2
Primary Topic
Oral and Maxillofacial Pathology
Type
article
Field-Weighted Citation Impact
0.99
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bone resorption marker RANKL in the diagnosis and treatment of patients with maxillary sinus cysts

Volodymyr O. Shkorbotun, Yaroslav S. Nachesa
2 citations
Inter Collegas
Oral and Maxillofacial Pathology
0.99
article

Bone resorption marker RANKL in the diagnosis and treatment of patients with maxillary sinus cysts

Volodymyr O. Shkorbotun, Yaroslav S. Nachesa
article en
2 citations

Abstract

Background. RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand) is a protein belonging to the tumor necrosis factor superfamily serving as a specific marker for osteoclast activation and osteolysis. Aim. To determine RANKL levels in the homogenates of Maxillary Sinus Cysts (MSC) at the time of their removal, investigate the correlation of these indicators with the presence of pathology in the upper row of projection teeth in the respective patients, and refine the timing for potential dental implantation or sinus lifting after sinusotomy based on these findings. Materials & Methods. The study included 25 patients aged 20–65 years who underwent surgical treatment for MSCs located on the inferior wall of the sinus. The research methods comprised general clinical, otorhinolaryngological, radiological, and pathohistological techniques and Enzyme-Linked ImmunoSorbent Assay (ELISA) for RANKL in the tissues of the removed cysts. Pathohistological examination revealed retention cysts in 11 patients and pseudocysts in 14 patients. The presence of dental pathology and active odontogenic processes at the time of cyst removal was established based on prospective clinical and radiological evaluations. The dynamics of mucoperiosteal defect regeneration in the MSC, considering RANKL levels, were assessed 3–6 months post-surgery. Results. In the postoperative period, 8 (32%) out of 25 patients exhibited odontogenic alteration processes in the tissues of the maxilla adjacent to the cysts. The RANKL concentration in these patients was [80.65±34.22] pg/µg of protein, while in the other 17 patients without signs of bone damage, it was [33.10±4.35] pg/µg of protein (p<0.05). The threshold RANKL concentration distinguishing these groups in this study was 51.50 pg/µg of protein. Conclusions. In patients with peri-apical bone changes in the maxilla in the projection area of the cysts (alveolar recess), the RANKL level in their homogenates is higher compared to patients without such pathology. Measuring RANKL levels in the homogenates of cysts removed during endonasal maxillary sinusotomy can serve as an additional indicator for planning postoperative dental treatment in these patients. Keywords: ENT-pathology, endoscopic rhinosurgery, histology, postoperative period, paranasal sinus x-ray, treatment.

Inter CollegasVol. 11(3)
Shupyk National Healthcare University of Ukraine (UA)
Good health and well-being
Openalex Percentile: Top 23%
Oral and Maxillofacial Pathology
0.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.